[The effect of cerebrolysin on the clinical symptoms and the course of ischemic encephalopathy].
Chukanova
E I
EI
D000596:Amino Acids / Q000191:economics / Q000627:therapeutic use*; D001921:Brain / Q000098:blood supply* / Q000187:drug effects; D002545:Brain Ischemia / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D006801:Humans; D001523:Mental Disorders / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology; D009069:Movement Disorders / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology; D018697:Nootropic Agents / Q000191:economics / Q000627:therapeutic use*
D000596:Amino Acids; D018697:Nootropic Agents; C006952:cerebrolysin